Intra-arterial chemotherapy combined with BCG immunotherapy is more effective than intra-arterial chemotherapy plus intravesical chemotherapy or standard BCG immunotherapy in preventing the recurrence and progression of high-risk non–muscle-invasive bladder cancer
Shuhang Luo(Chinese Academy of Medical Sciences & Peking Union Medical College), Bin Huang(North Sichuan Medical University), Lingwu Chen(Sun Yat-sen University), Wenhao Zhan(Universitat Autònoma de Barcelona), Wumier Wusimanjiang(Sun Yat-sen University), Hao Lin(Sun Yat-sen University), Junxing Chen(Sun Yat-sen University), Jinwen Liu(Sun Yat-sen University), Yukun Wu(Sanofi (United States)), Enyou Si(Sun Yat-sen University), Rui Yang(Aerospace Center Hospital)
Cited by 1
Related Papers
Diagnosis and prognosis of neutrophil gelatinase-associated lipocalin for acute kidney injury with sepsis: a systematic review and meta-analysis
|Critical Care|2016|144
Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2
|Journal of Experimental & Clinical Cancer Research|2019|105
Use of Vesical Imaging-Reporting and Data System (VI-RADS) for detecting the muscle invasion of bladder cancer: a diagnostic meta-analysis
|European Radiology|2020|96
Jak/STAT signaling is involved in the inflammatory infiltration of the kidneys in MRL/lpr mice
|Lupus|2010|80
Overexpression of Pim-1 in bladder cancer
|Journal of Experimental & Clinical Cancer Research|2010|79